Melanocyte biology and skin pigmentation.

Physiological factors that regulate skin pigmentation. Biofactors (2009) 1.93

TRPM1 forms ion channels associated with melanin content in melanocytes. Sci Signal (2009) 1.75

Reprogramming cellular identity for regenerative medicine. Cell (2012) 1.71

Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer (2009) 1.69

Regulation of MITF stability by the USP13 deubiquitinase. Nat Commun (2011) 1.62

Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Genes Dev (2010) 1.61

Basis for enhanced barrier function of pigmented skin. J Invest Dermatol (2014) 1.49

Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003--2004. Environ Health Perspect (2008) 1.46

Melanocytes in the skin--comparative whole transcriptome analysis of main skin cell types. PLoS One (2014) 1.44

Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells. PLoS Genet (2015) 1.43

The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science (2014) 1.37

Integration of ChIP-seq and machine learning reveals enhancers and a predictive regulatory sequence vocabulary in melanocytes. Genome Res (2012) 1.35

High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer (2011) 1.35

The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet (2008) 1.34

Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell (2010) 1.31

Angiogenesis in melanoma. Semin Oncol (2007) 1.30

A role for ATF2 in regulating MITF and melanoma development. PLoS Genet (2010) 1.28

Generation of human melanocytes from induced pluripotent stem cells. PLoS One (2011) 1.27

Signaling pathways in melanosome biogenesis and pathology. Int J Biochem Cell Biol (2010) 1.27

The expression of melanin-based plumage is separately modulated by exogenous oxidative stress and a melanocortin. Proc Biol Sci (2009) 1.23

Foxd3 controls melanophore specification in the zebrafish neural crest by regulation of Mitf. Dev Biol (2009) 1.22

Genetic risk factors for melanoma. Hum Genet (2009) 1.21

Polarization-sensitive hyperspectral imaging in vivo: a multimode dermoscope for skin analysis. Sci Rep (2014) 1.15

Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling. Nat Med (2013) 1.15

An intracellular antioxidant determines the expression of a melanin-based signal in a bird. PLoS One (2008) 1.14

Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc (2008) 1.13

Human pigmentation genes under environmental selection. Genome Biol (2012) 1.11

PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07

Mechanisms regulating melanogenesis. An Bras Dermatol (2013) 1.07

Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res (2008) 1.07

Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion. Exp Dermatol (2009) 1.07

UV light phototransduction activates transient receptor potential A1 ion channels in human melanocytes. Proc Natl Acad Sci U S A (2013) 1.06

Genetic and environmental melanoma models in fish. Pigment Cell Melanoma Res (2010) 1.04

A genomic screen identifies TYRO3 as a MITF regulator in melanoma. Proc Natl Acad Sci U S A (2009) 1.04

UVA phototransduction drives early melanin synthesis in human melanocytes. Curr Biol (2011) 1.03

PKA-mediated phosphorylation of ATR promotes recruitment of XPA to UV-induced DNA damage. Mol Cell (2014) 1.03

Role of semiconductivity and ion transport in the electrical conduction of melanin. Proc Natl Acad Sci U S A (2012) 1.03

Lamellipodin and the Scar/WAVE complex cooperate to promote cell migration in vivo. J Cell Biol (2013) 1.02

Pigmentation pathway evolution after whole-genome duplication in fish. Genome Biol Evol (2009) 1.01

Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc Natl Acad Sci U S A (2009) 1.00

Keratinocyte-derived laminin-332 promotes adhesion and migration in melanocytes and melanoma. J Biol Chem (2011) 0.99

MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation. Pigment Cell Melanoma Res (2014) 0.97

Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. PLoS One (2010) 0.97

Molecular nevogenesis. Dermatol Res Pract (2011) 0.97

Evidence that stress to the epidermal barrier influenced the development of pigmentation in humans. Pigment Cell Melanoma Res (2009) 0.96

FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ (2011) 0.93

Whales use distinct strategies to counteract solar ultraviolet radiation. Sci Rep (2013) 0.92

Spatial and temporal localization of the melanocortin 1 receptor and its ligand α-melanocyte-stimulating hormone during cutaneous wound repair. J Histochem Cytochem (2011) 0.91

KIT is a frequent target for epigenetic silencing in cutaneous melanoma. J Invest Dermatol (2014) 0.91

Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. Pigment Cell Melanoma Res (2007) 0.91

Stem cells and targeted approaches to melanoma cure. Mol Aspects Med (2013) 0.90

Differentiation of zebrafish melanophores depends on transcription factors AP2 alpha and AP2 epsilon. PLoS Genet (2010) 0.90

Selection signatures in worldwide sheep populations. PLoS One (2014) 0.90

Improved eye- and skin-color prediction based on 8 SNPs. Croat Med J (2013) 0.90

Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humans. Am J Hum Biol (2010) 0.89

Melanin: the biophysiology of oral melanocytes and physiological oral pigmentation. Head Face Med (2014) 0.88

A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells. PLoS One (2011) 0.88

A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene. PLoS One (2011) 0.88

A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer. Cancer Causes Control (2008) 0.88

Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech (2008) 0.88

Signaling Pathways in Melanogenesis. Int J Mol Sci (2016) 0.87

Identification of QTL for UV-protective eye area pigmentation in cattle by progeny phenotyping and genome-wide association analysis. PLoS One (2012) 0.87

Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications. Int J Mol Sci (2015) 0.86

Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk. Biochem Biophys Res Commun (2013) 0.86

Membrane-Associated Transporter Protein (MATP) Regulates Melanosomal pH and Influences Tyrosinase Activity. PLoS One (2015) 0.86

Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders. Evid Based Complement Alternat Med (2014) 0.86

Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression. J Biol Chem (2012) 0.85

Recent discoveries in the genetics of melanoma and their therapeutic implications. Arch Immunol Ther Exp (Warsz) (2007) 0.85

The peripheral clock regulates human pigmentation. J Invest Dermatol (2014) 0.85

Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica (Cairo) (2013) 0.85

A blue spectral shift of the hemoglobin soret band correlates with the age (time since deposition) of dried bloodstains. PLoS One (2010) 0.84

Condensed tannins from Ficus virens as tyrosinase inhibitors: structure, inhibitory activity and molecular mechanism. PLoS One (2014) 0.84

High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma. PLoS One (2012) 0.84

Repigmentation of cutaneous scars depends on original wound type. J Anat (2013) 0.84

Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study. J Invest Dermatol (2015) 0.83

Morph-specific genetic and environmental variation in innate and acquired immune response in a color polymorphic raptor. Oecologia (2015) 0.83

Characterization of the mantle transcriptome of yesso scallop (Patinopecten yessoensis): identification of genes potentially involved in biomineralization and pigmentation. PLoS One (2015) 0.83

Genetic modulation of the iris transillumination defect: a systems genetics analysis using the expanded family of BXD glaucoma strains. Pigment Cell Melanoma Res (2013) 0.83

S-(-)-10,11-dihydroxyfarnesoic acid methyl ester inhibits melanin synthesis in murine melanocyte cells. Int J Mol Sci (2014) 0.83

Plants from Brazilian Cerrado with potent tyrosinase inhibitory activity. PLoS One (2012) 0.83

Controlled insertional mutagenesis using a LINE-1 (ORFeus) gene-trap mouse model. Proc Natl Acad Sci U S A (2013) 0.83

Acute sun damage and photoprotective responses in whales. Proc Biol Sci (2010) 0.83

Effect of ginseng and ginsenosides on melanogenesis and their mechanism of action. J Ginseng Res (2014) 0.82

Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues. G Ital Dermatol Venereol (2010) 0.82

In vitro techniques to assess the proficiency of skin care cosmetic formulations. Pharmacogn Rev (2013) 0.82

Identification of hair shaft progenitors that create a niche for hair pigmentation. Genes Dev (2017) 0.82

Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma. Open Cancer J (2011) 0.81

Lipoteichoic acid isolated from Lactobacillus plantarum inhibits melanogenesis in B16F10 mouse melanoma cells. Mol Cells (2015) 0.81

Alpha-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes. Nucleic Acids Res (2010) 0.81

Melanin photosensitization and the effect of visible light on epithelial cells. PLoS One (2014) 0.81

Effect of xanthohumol on melanogenesis in B16 melanoma cells. Exp Mol Med (2008) 0.81

Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk. Br J Dermatol (2008) 0.81

Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice. Sci Rep (2016) 0.80

Red Hair, Light Skin, and UV-Independent Risk for Melanoma Development in Humans. JAMA Dermatol (2016) 0.80

Pale and dark reddish melanic tawny owls differentially regulate the level of blood circulating POMC prohormone in relation to environmental conditions. Oecologia (2011) 0.80

Melanocortin receptor 1 and black pigmentation in the Japanese ornamental carp (Cyprinus carpio var. Koi). Front Genet (2013) 0.80

Melanocytes derived from transgene-free human induced pluripotent stem cells. J Invest Dermatol (2013) 0.80

Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor. Melanoma Res (2011) 0.80

Keratin 76 is required for tight junction function and maintenance of the skin barrier. PLoS Genet (2014) 0.80

Photoprotective and antioxidant effects of Rhubarb: inhibitory action on tyrosinase and tyrosine kinase activities and TNF-α, IL-1α and α-MSH production in human melanocytes. BMC Complement Altern Med (2013) 0.80

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28

Integrative analysis of the melanoma transcriptome. Genome Res (2010) 8.46

Chromatin structure analyses identify miRNA promoters. Genes Dev (2008) 5.40

High-throughput mapping of the chromatin structure of human promoters. Nat Biotechnol (2007) 5.24

Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell (2007) 4.75

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. Cancer Res (2010) 4.71

MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med (2006) 4.60

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res (2013) 4.28

Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol (2005) 3.68

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell (2013) 3.63

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res (2004) 3.20

Major response to imatinib mesylate in KIT-mutated melanoma. J Clin Oncol (2008) 3.16

Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science (2004) 3.12

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature (2011) 2.96

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell (2004) 2.80

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature (2009) 2.77

Melanoma: from mutations to medicine. Genes Dev (2012) 2.59

From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer (2012) 2.46

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35

Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene (2003) 2.19

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol (2013) 2.11

Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature (2006) 2.09

Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell (2010) 2.06

Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J Cell Biol (2002) 2.00

An oncogenic role for ETV1 in melanoma. Cancer Res (2010) 1.94

TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res (2007) 1.93

MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol (2003) 1.90

Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell (2010) 1.86

NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell (2002) 1.79

UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res (2008) 1.78

A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell (2013) 1.75

Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin Cancer Res (2008) 1.73

Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A (2003) 1.73

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A (2013) 1.72

Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease. Curr Mol Med (2002) 1.69

Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res (2004) 1.64

Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem (2005) 1.62

Regulation of MITF stability by the USP13 deubiquitinase. Nat Commun (2011) 1.62

Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Genes Dev (2010) 1.61

Transdifferentiation of the retina into pigmented cells in ocular retardation mice defines a new function of the homeodomain gene Chx10. Development (2004) 1.58

Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol (2005) 1.54

Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J Clin Oncol (2011) 1.47

c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem (2006) 1.42

Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell (2006) 1.41

Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem (2004) 1.40

Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform. Gene (2005) 1.35

How sunlight causes melanoma. Curr Oncol Rep (2010) 1.34

A new era: melanoma genetics and therapeutics. J Pathol (2010) 1.32

Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell (2010) 1.31

Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol (2002) 1.30

SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res (2003) 1.22

Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Dev Cell (2010) 1.22

Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage. Pigment Cell Melanoma Res (2008) 1.21

Feed-forward microprocessing and splicing activities at a microRNA-containing intron. PLoS Genet (2011) 1.18

Pathways and therapeutic targets in melanoma. Oncotarget (2014) 1.17

Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA. Nucleic Acids Res (2013) 1.16

Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF. J Biol Chem (2001) 1.16

A melanoma molecular disease model. PLoS One (2011) 1.15

Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem (2003) 1.14

Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. Cancer Res (2010) 1.14

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology (2013) 1.13

NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nat Cell Biol (2002) 1.12

Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone (2004) 1.10

Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci U S A (2011) 1.09

The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor. J Biol Chem (2002) 1.08

PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07

A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J Biol Chem (2003) 1.07

Inhibition of the met receptor in mesothelioma. Clin Cancer Res (2005) 1.05

Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J (2007) 1.02

New strategies in metastatic melanoma: oncogene-defined taxonomy leads to therapeutic advances. Clin Cancer Res (2011) 1.02

Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line. J Biol Chem (2010) 1.02

Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr Opin Oncol (2009) 1.02

Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagn Mol Pathol (2011) 1.01

Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Mol Med (2007) 1.01

Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl Immunohistochem Mol Morphol (2002) 1.00

Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci (2006) 1.00

Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation. Clin Cancer Res (2014) 0.98

Transcriptional regulation in melanoma. Hematol Oncol Clin North Am (2009) 0.98

YY1 regulates melanocyte development and function by cooperating with MITF. PLoS Genet (2012) 0.93

The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis. Mol Cell Biol (2004) 0.91

Lighting a path to pigmentation: mechanisms of MITF induction by UV. Pigment Cell Melanoma Res (2010) 0.91

MiT transcription factor associated malignancies in man. Cell Cycle (2007) 0.90

Dual roles of lineage restricted transcription factors: the case of MITF in melanocytes. Transcription (2012) 0.90

How does pheomelanin synthesis contribute to melanomagenesis?: Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis. Bioessays (2013) 0.88

Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. Cancer Res (2009) 0.88

Specification and loss of melanocyte stem cells. Semin Cell Dev Biol (2008) 0.87

Key discoveries in melanocyte development. J Invest Dermatol (2011) 0.87

Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma. Nat Clin Pract Oncol (2008) 0.85

Induction of apoptosis in cancer: new therapeutic opportunities. Ann Med (2002) 0.85

Dynamic and transient cancer stem cells nurture melanoma. Nat Med (2010) 0.84

Transcription factor E3, a major regulator of mast cell-mediated allergic response. J Allergy Clin Immunol (2012) 0.84

Notch and melanocytes: diverse outcomes from a single signal. J Invest Dermatol (2008) 0.84

Central role for cAMP signaling in pigmentation and UV resistance. Cell Cycle (2011) 0.83

Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. J Natl Cancer Inst (2012) 0.82

Developing melanoma therapeutics: overview and update. Wiley Interdiscip Rev Syst Biol Med (2013) 0.82

Stemming the tanning bed epidemic: time for action. J Natl Compr Canc Netw (2012) 0.82

Melanoma and viagra: an unexpected connection. Pigment Cell Melanoma Res (2011) 0.81

High-throughput, high-content screening for novel pigmentation regulators using a keratinocyte/melanocyte co-culture system. Exp Dermatol (2014) 0.81